Literature DB >> 3403985

Solubilisation effect of Nonidet P-40, triton X-100 and CHAPS in the detection of MHC-like glycoproteins.

M O Labeta1, N Fernandez, H Festenstein.   

Abstract

We have analysed the differential solubilisation effect of three detergents on cell-membrane histocompatibility glycoproteins. Two nonionic detergents (Nonidet P-40 and Triton X-100) which are extensively used in the extraction of MHC proteins and a zwitterionic detergent (CHAPS) which is sulphobetaine derivative of cholic acid were used. An AKR (H-2k) derived spontaneous leukaemic cell line--424--was used as the experimental model. In this tumour cell line a class I-like antigen is expressed but not directly detected by cell-binding radioimmunoassay or immunoprecipitation from NP-40 or Triton X-100 solubilised glycoproteins. However, 46 kDa and 12 kDa bands consistent with the classical H-2 class I pattern were seen by SDS-PAGE after immunoprecipitation with the 34.5.8 anti-H-2Dd MoAb using CHAPS solubilised 424 glycoproteins. The H-2Dd-reactive molecule appears to be associated with at least one of the syngeneic class I specificities (H-2Kk, H-2Dk) and not accessible to react with the specific anti H-2Dd MoAb. The detergents NP-40 and Triton X-100 appear to be less efficient than CHAPS in breaking protein-protein interactions. This property of CHAPS permitted the adequate solubilisation of the novel antigen and its direct detection. The results of this study suggest that the alternative use of a non-denaturing zwitterionic detergent may contribute to the detection and characterisation of MHC-related, membrane-bound proteins of tumours and normal cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403985     DOI: 10.1016/0022-1759(88)90043-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Determination of endogenous serum proteins in normal and oedematous brain tissue of cat by rocket and crossed immunoelectrophoresis.

Authors:  J Szymas; K A Hossmann
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

2.  Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.

Authors:  Luca Musante; Mayank Saraswat; Elodie Duriez; Barry Byrne; Alessandra Ravidà; Bruno Domon; Harry Holthofer
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

3.  Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics.

Authors:  Gail Lewis Phillips; Jun Guo; James R Kiefer; William Proctor; Daniela Bumbaca Yadav; Noel Dybdal; Ben-Quan Shen
Journal:  Breast Cancer Res Treat       Date:  2021-10-27       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.